tiprankstipranks
YD Bio Limited (YDES)
NASDAQ:YDES
US Market
YDES
YD Bio Limited
RESEARCH TOOLSreports

YD Bio Limited (YDES) Income Statement

20 Followers

YD Bio Limited Income Statement

Last quarter (Q2 2025), YD Bio Limited's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, YD Bio Limited's net income was $-2.21M. See YD Bio Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 510.36K$ 350.13K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 155.36K$ 153.44K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 1.62M$ 163.29K$ 2.32M$ 1.72M$ 344.22K
Depreciation and Amortization
$ 104.73K$ 2.45K$ 0.00$ 0.00$ 0.00
EBITDA
$ -1.28M$ 22.25K$ 3.79M$ 8.70M$ -2.54M
Operating Income
$ -1.46M$ -9.85K$ -2.32M$ -1.72M$ -344.22K
Other Income/Expenses
$ 75.45K$ 27.50K$ 6.11M$ 10.43M$ -2.19M
Pretax Income
$ -1.39M$ 17.65K$ 3.79M$ 8.70M$ -2.54M
Net Income
$ -1.41M$ 13.56K$ 3.79M$ 8.70M$ -2.54M
Per Share Metrics
Basic EPS
$ -0.56$ 0.00$ 0.41$ 0.59$ -0.17
Diluted EPS
$ -0.56$ 0.00$ 0.41$ 0.59$ -0.17
Weighted Average Shares Outstanding
 4.15M 70.10M 9.29M 14.63M 14.63M
Weighted Average Shares Outstanding (Diluted)
 4.15M 70.10M 9.29M 14.63M 14.63M
Currency in USD

YD Bio Limited Earnings and Revenue History